|
Sep 25
|
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
|
|
Sep 5
|
Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal?
|
|
Sep 4
|
Why Is CRISPR Therapeutics (CRSP) Down 7.7% Since Last Earnings Report?
|
|
Sep 2
|
3 Monster Biotech Stocks to Buy Before 2025
|
|
Aug 26
|
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
|
|
Jul 29
|
Analysts Estimate CRISPR Therapeutics AG (CRSP) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 24
|
CRISPR Therapeutics Nears 52-Week Low. Time to Buy?
|
|
Jul 23
|
CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know
|
|
Jul 23
|
Is a Beat in the Cards for CRISPR (CRSP) in Q2 Earnings?
|
|
Jul 22
|
3 Gene Editing Stocks Shaping the Future of Medicine
|
|
Jul 11
|
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid
|
|
Jul 10
|
Here's Why CRISPR Therapeutics AG (CRSP) Gained But Lagged the Market Today
|
|
Jun 12
|
7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom
|
|
May 15
|
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
|
|
May 14
|
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
|
|
May 13
|
15 Best ARK Stocks To Buy Now
|
|
May 13
|
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
|
|
May 11
|
Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher
|
|
May 10
|
CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst Net Income Forecast
|
|
May 10
|
We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow
|